JOHNSON & JOHNSON 4

Joaquin Duato, CEO and Chairman of Johnson & Johnson, exercised 123,291 stock options at $115.67 and sold 123,291 Johnson & Johnson common shares for about $32.4 million on August 13, 2026.

On August 13, 2026, Johnson & Johnson CEO and Chairman Joaquin Duato exercised 123,291 employee stock options at $115.67 per share, acquiring an equivalent number of common shares, and on the same day sold a total of 123,291 common shares in two open-market transactions at approximately $261–$262 per share. The gross value of the option exercise was about $14.3 million, with an intrinsic (pre-tax) gain of roughly $18.0 million based on the sale prices, while the sales themselves totaled approximately $32.4 million in proceeds. These transactions appear to be a classic “cashless” or monetizing exercise-and-sell sequence, leaving Duato with 275,967 directly held shares plus additional indirect holdings through a 401(k) plan and his spouse, which together retain material exposure to Johnson & Johnson’s equity.

Filing Facts

CIK

200406

Ticker

JNJ

Form

4

Source Type

fda

Accession

0000200406-26-000173

Alert Tier

7